Mio Ebato

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

Hiroki Maruyama, Kaori Miyata, Mariko Mikame et al. · Genetics in Medicine · 2018 · 93 citations · Full text

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki et al. · Circulation · 2022 · 56 citations · Full text

Relation Between Echocardiogram-Based Cardiac Parameters and Outcome in Heart Failure With Preserved and Reduced Ejection Fraction

Masaru Obokata, Masaaki Takeuchi, Kazuaki Negishi et al. · The American Journal of Cardiology · 2016 · 25 citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +10

Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy　― The HORIZON-HCM Study ―

Hiroaki Kitaoka, Masaki Ieda, Mio Ebato et al. · Circulation Journal · 2024 · 19 citations · Full text

Association of Potentially Inappropriate Medications With All-Cause Mortality in the Elderly Acute Decompensated Heart Failure Patients: Importance of Nonsteroidal Anti-Inflammatory Drug Prescription

Tomiko Sunaga, Azusa Yokoyama, Shoko Nakamura et al. · Cardiology Research · 2020 · 17 citations · Full text